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Supplementary Table 1. Spearman correlations of serum amino acids, biogenic amines, and amino acid metabolites with gut 
permeability (L:M ratio), adjusted by age, gender, and village 
 
Analyte r P Analyte r P 
Tryptophan -0.214 0.0001* Alanine 0.006 0.92 
Isoleucine -0.030 0.60 Aspartic acid -0.018 0.75 
Leucine -0.005 0.93 Glutamate 0.135 0.017* 
Valine -0.011 0.85 Citrulline -0.132 0.019* 
Methionine -0.005 0.94 Ornithine -0.175 0.002* 
Histidine 0.074 0.19 Alpha-aminoadipic acid -0.008 0.88 
Phenylalanine -0.027 0.63 Kynurenine 0.031 0.58 
Threonine -0.098 0.09 Creatinine 0.039 0.50 
Lysine -0.015 0.79 Spermine -0.027 0.64 
Asparagine -0.018 0.75 Putrescine 0.028 0.63 
Glutamine -0.046 0.42 Serotonin 0.155 0.006* 
Arginine -0.056 0.33 Taurine 0.143 0.013* 
Glycine 0.021 0.71 Total dimethylarginine 0.014 0.82 
Proline 0.062 0.27 Symmetric dimethylarginine 0.045 0.43 
Serine 0.061 0.28 Asymmetric dimethylarginine 0.044 0.44 
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Tyrosine -0.086 0.13  
*Significant at q-value < 0.05 and p-value < 0.027 
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Supplementary Table 2. Spearman correlations of serum sphingolipids1 and acylcarnitines  
with gut permeability (L:M ratio), adjusted by age, gender, and village 
 
Analyte r P Analyte r P 
SM (OH) C14:1 -0.118 0.037 SM C24:1 -0.042 0.46 
SM (OH) C16:1 -0.051 0.37 SM C26:0 0.003 0.96 
SM (OH) C22:1 -0.072 0.21 SM C26:1 0.011 0.85 
SM (OH) C22:2 -0.103 0.07 Carnitine (C0) 0.070 0.22 
SM (OH) C24:1 -0.072 0.21 Acetylcarnitine (C2) 0.097 0.08 
SM C16:0 -0.136 0.016* Propionylcarnitine (C3) 0.081 0.16 
SM C16:1 -0.143 0.011* Butyrylcarnitine (C4) 0.049 0.38 
SM C18:0 -0.075 0.18 Hydroxybutyrylcarnitine (C4-OH [C3-
DC]) 
0.105 0.07 
SM C18:1 -0.072 0.20 Hexadecanoylcarnitine (C16) -0.055 0.38 
SM C20:2 -0.073 0.19 Octadecenoylcarnitine (C18) -0.005 0.93 
SM C22:3 -0.072 0.20 Octadecadienylcarnitine (C18:1) -0.059 0.31 
SM C24:0 -0.040 0.48  
1Abbreviations for lipid nomenclature are described in the Methods section. 
*Significant at q-value < 0.05 and p-value < 0.027  
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Supplementary Table 3. Spearman correlations of serum glycerophospholipids1  
with gut permeability (L:M ratio), adjusted by age, gender, and village 
 
Analyte r P Analyte r P 
LysoPC a C16:0 -0.133 0.018* PC aa C42:0 -0.077 0.18 
LysoPC a C16:1 -0.073 0.20 PC aa C42:1 -0.077 0.18 
LysoPC a C17:0 -0.044 0.44 PC aa C42:2 -0.093 0.10 
LysoPC a C18:0 -0.146 0.009* PC aa C42:4 -0.068 0.23 
LysoPC a C18:1 -0.125 0.027 PC aa C42:5 -0.040 0.48 
LysoPC a C18:2 -0.142 0.012* PC aa C42:6 -0.071 0.22 
LysoPC a C20:3 -0.119 0.035 PC ae C30:1 0.005 0.92 
LysoPC a C20:4 -0.134 0.018* PC ae C30:2 -0.084 0.13 
LysoPC a C24:0 -0.051 0.37 PC ae C32:1 -0.086 0.13 
LysoPC a C26:0 0.013 0.82 PC ae C32:2 -0.082 0.15 
LysoPC a C26:1 0.001 0.99 PC ae C34:0 0.013 0.81 
LysoPC a C28:0 0.041 0.48 PC ae C34:1 -0.018 0.75 
LysoPC a C28:1 -0.020 0.72 PC ae C34:2 -0.037 0.51 
PC aa C24:0 -0.023 0.68 PC ae C34:3 -0.095 0.10 
PC aa C28:1 -0.020 0.72 PC ae C36:0 -0.091 0.11 
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PC aa C30:0 -0.066 0.24 PC ae C36:1 -0.042 0.46 
PC aa C30:2 -0.074 0.19 PC ae C36:2 -0.014 0.80 
PC aa C32:0 -0.041 0.47 PC ae C36:3 -0.054 0.35 
PC aa C32:1 -0.033 0.56 PC ae C36:4 -0.121 0.03 
PC aa C32:2 -0.019 0.74 PC ae C36:5 -0.095 0.09 
PC aa C32:3 -0.045 0.43 PC ae C38:0 -0.099 0.08 
PC aa C34:1 -0.058 0.31 PC ae C38:1 -0.084 0.14 
PC aa C34:2 -0.082 0.15 PC ae C38:2 -0.014 0.80 
PC aa C34:3 -0.048 0.39 PC ae C38:3 -0.060 0.29 
PC aa C34:4 -0.085 0.14 PC ae C38:4 -0.071 0.21 
PC aa C36:0 -0.072 0.21 PC ae C38:5 -0.100 0.08 
PC aa C36:1 -0.116 0.04 PC ae C38:6 -0.091 0.11 
PC aa C36:2 -0.119 0.04 PC ae C40:1 -0.167 0.003* 
PC aa C36:3 -0.094 0.10 PC ae C40:2 -0.051 0.37 
PC aa C36:4 -0.090 0.11 PC ae C40:3 -0.066 0.25 
PC aa C36:5 -0.114 0.04 PC ae C40:4 -0.073 0.20 
PC aa C36:6 -0.100 0.08 PC ae C40:5 -0.108 0.06 
PC aa C38:0 -0.088 0.12 PC ae C40:6 -0.107 0.06 
PC aa C38:1 -0.030 0.60 PC ae C42:1 -0.086 0.13 
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PC aa C38:3 -0.105 0.06 PC ae C42:2 -0.068 0.23 
PC aa C38:4 -0.096 0.09 PC ae C42:3 -0.084 0.14 
PC aa C38:5 -0.066 0.25 PC ae C42:4 -0.021 0.71 
PC aa C38:6 -0.094 0.09 PC ae C42:5 -0.087 0.13 
PC aa C40:2 -0.094 0.09 PC ae C44:3 -0.134 0.018* 
PC aa C40:3 -0.108 0.06 PC ae C44:4 -0.052 0.37 
PC aa C40:4 -0.067 0.24 PC ae C44:5 -0.087 0.13 
PC aa C40:5 -0.053 0.35 PC ae C44:6 -0.106 0.06 
PC aa C40:6 -0.120 0.03  
1Abbreviations for lipid nomenclature are described in the Methods section. 
*Significant at q-value < 0.05 and p-value < 0.027 
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Supplementary Table 4. Serum amino acids, biogenic amines, and amino acid metabolite concentrations  





(n = 68) 
EED 







(n = 68) 
EED 
(n = 247) 
P1 
Median IQR2  Median IQR  Median IQR  Median IQR  
Tryptophan 36.5 20.6, 51.8 36.7 25.2, 50.8 0.66 Alanine 465.7 395.5, 592.1 492.6 418.6, 580.2 0.42 
Isoleucine 51.1 44.6, 60.2 58.6 49.2, 70.0 0.004 Aspartic acid 54.4 47.3, 68.3 56.7 42.3, 70.3 0.82 
Leucine 127.4 100.5, 150.2 138.2 116.4, 167.3 0.003 Glutamate 176.9 140.6, 218.8 251.7 156.9, 334.7 <0.0001 
Valine 130.9 114.6, 157.3 146.4 125.0, 176.6 0.002 Citrulline 20.4 16.7, 26.3 20.3 16.1, 26.6 0.45 
Methionine 20.6 17.9, 24.8 23.8 19.4, 28.7 0.003 Ornithine 69.1 56.1, 90.2 74.9 54.3, 116.5 0.16 
Histidine 83.4 70.1, 97.4 92.6 75.9, 112.4 0.001 Alpha- 
aminoadipic acid 
1.14 0.81, 9.66 1.07 0.70, 3.17 0.58 
Phenylalanine 81.9 70.6, 94.3 85.5 75.5, 99.5 0.05 Kynurenine 2.61 2.02, 3.16 2.82 2.09, 3.58 0.08 
Threonine 89.7 72.1, 105.4 89.1 69.6, 118.1 0.76 Creatinine 21.8 17.7, 25.4 21.3 17.7, 25.1 0.72 
Lysine 127.8 108.8, 147.7 147.5 112.8, 185.0 0.007 Spermine 0.09 0.06, 0.14 0.08 0.05, 0.13 0.05 
Asparagine 54.4 47.3, 68.3 56.7 42.3, 70.3 0.83 Putrescine 0.12 0.07, 0.17 0.13 0.07, 0.19 0.59 
Glutamine 523.4 442.5, 642.5 535.3 451.2, 627.0 0.71 Serotonin 1.14 0.72, 1.72 1.40 0.96, 1.98 0.02 
Arginine 87.4 71.4, 103.9 82.6 67.7, 97.9 0.26 Taurine 152.1 113.7, 179.8 182.7 150.9, 226.9 <0.0001 
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Glycine 304.4 255.1, 362.8 327.8 265.0, 397.5 0.07 Total 
dimethylarginine 
1.25 0.94, 1.46 1.20 0.90, 1.55 0.97 
Proline 179.7 156.2, 221.1 191.5 163.3, 226.4 0.38 Symmetric 
dimethylarginine 
0.49 0.16, 0.73 0.42 0.09, 0.70 0.28 
Serine 143.3 129.3, 161.6 165.8 138.0, 208.1 0.0002 Asymmetric 
dimethylarginine 
0.88 0.72, 1.03 0.92 0.75, 1.13 0.22 
Tyrosine 60.8 48.3, 71.9 61.1 52.0, 72.9 0.60  
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(n = 68) 
EED 
(n = 247) 
P2 
 
Analyte in µmol/L 
 
No EED 
(n = 68) 
EED 
(n = 247) 
P2 
 
Median IQR3 Median IQR  Median IQR Median IQR 
SM (OH) C14:1 2.34 1.95, 2.78 2.23 1.94, 2.72 0.45 SM C24:1 38.5 32.9, 43.2 39.3 32.9, 44.5 0.69 
SM (OH) C16:1 2.02 1.68, 2.25  2.04 1.68, 2.35 0.78 SM C26:0 0.20 0.16, 0.25 0.19 0.017, 0.23 0.61 
SM (OH) C22:1 7.50 6.11, 9.04 7.38 6.25, 8.69 0.84 SM C26:1 0.28 0.23, 0.34 0.27 0.22, 0.31 0.19 
SM (OH) C22:2 4.69 3.90, 5.47 4.69 3.96, 5.38 0.97 Carnitine (C0) 20.5 17.4, 26.6 22.3 18.5, 28.4 0.05 
SM (OH) C24:1 0.87 0.71, 1.08 0.85 0.72, 1.02 0.36 Acetylcarnitine (C2) 3.36 2.80, 4.35 4.03 2.87, 6.79 0.003 
SM C16:0 96.8 79.6, 115.0 88.0 77.0, 105.2 0.08 Proprionylcarnitine (C3) 0.46 0.35, 0.57 0.50 0.39, 0.65 0.07 
SM C16:1 9.05 7.24, 11.1 8.60 7.42, 10.4 0.21 Butyrylcarnitine (C4) 0.23 0.17, 0.31 0.29 0.19, 0.36 0.01 
SM C18:0 17.7 15.0, 22.8 18.1 14.1, 22.5 0.64 Hydroxybutyrylcarnitine 
(C4-OH [C3-DC])  
0.37 0.27, 0.48 0.38 0.28, 0.48 0.80 
SM C18:1 6.11 5.10, 7.92 6.27 5.35, 7.46 0.99 Hexadecanoylcarnitine 
(C16) 
0.19 0.16, 0.24 0.21 0.16, 0.26 0.05 
SM C20:2 0.59 0.49, 0.70 0.54 0.44, 0.66 0.05 Octadecenoylcarnitine 
(C18) 
0.12 0.10, 0.16 0.14 0.10, 0.17 0.03 
SM C22:3 5.79 4.73, 7.00 5.65 4.45, 6.79 0.29 Octadecadienylcarnitine 0.10 0.08, 0.12 0.11 0.08, 0.13 0.17 
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(C18:1) 
SM C24:0 20.1 17.5, 24.8 20.8 17.9, 23.8 0.99  
1Abbreviations for lipid nomenclature are described in the Methods section. 
2Wilcoxon rank-sum test 
 
3Interquartile range 
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(n = 68) 
EED 
(n = 247) 
P2 Analyte in 
µmol/L 
No EED 
(n = 68) 
EED 
(n = 247) 
P2 
Median IQR3 Median IQR Median IQR Median IQR 
LysoPC a C16:0 133.6 110.2, 174.6 157.0 108.5, 226.9 0.02 PC aa C42:0 0.73 0.60, 0.87 0.64 0.52, 0.77 0.002 
LysoPC a C16:1 3.01 2.34, 3.94 3.21 2.34, 4.30 0.52 PC aa C42:1 0.42 0.34, 0.49 0.38 0.30, 0.46 0.02 
LysoPC a C17:0 1.99 1.63, 2.80 2.61 1.81, 3.67 0.001 PC aa C42:2 0.26 0.21, 0.29 0.23 0.17, 0.28 0.02 
LysoPC a C18:0 41.8 35.7, 50.1 49.4 34.8, 75.1 0.01 PC aa C42:4 0.23 0.20, 0.29 0.23 0.19, 0.29 0.59 
LysoPC a C18:1 20.3 15.5, 24.3 21.2 16.4, 25.9 0.19 PC aa C42:5 0.41 0.34, 0.47 0.41 0.33, 0.50 0.88 
LysoPC a C18:2 21.8 17.7, 30.5 21.6 16.8, 27.0 0.45 PC aa C42:6 0.53 0.43, 0.61 0.47 0.40, 0.61 0.12 
LysoPC a C20:3 2.41 1.73, 3.04 2.51 1.83, 3.37 0.30 PC ae C30:1 0.19 0.13, 0.26 0.18 0.13, 0.24 0.54 
LysoPC a C20:4 9.68 7.97, 12.40 10.81 8.28, 14.67 0.05 PC ae C30:2 0.07 0.06, 0.09 0.06 0.05, 0.08 0.019 
LysoPC a C24:0 0.41 0.34, 0.48 0.41 0.34, 0.49 0.78 PC ae C32:1 2.40 1.96, 3.26 2.16 1.79, 2.73 0.009 
Lyso PC a C26:0 0.56 0.42, 0.71 0.52 0.40, 0.66 0.29 PC ae C32:2 0.47 0.39, 0.59 0.43 0.36, 0.50 0.006 
LysoPC a C26:1 0.30 0.24, 0.37 0.28 0.34, 0.36 0.40 PC ae C34:0 0.80 0.67, 1.14 0.82 0.66, 1.06 0.73 
LysoPC a C28:0 0.42 0.34, 0.49 0.45 0.38, 0.54 0.08 PC ae C34:1 6.58 4.81, 8.59 5.62 4.43, 7.10 0.02 
LysoPC a C28:1 0.47 0.41, 0.54 0.48 0.40, 0.56 0.65 PC ae C34:2 5.33 4.14, 6.64 4.98 4.28, 5.82 0.13 
PC aa C24:0 0.19 0.15, 0.23 0.19 0.16. 0.24 0.52 PC ae C34:3 4.24 3.43, 4.98 3.91 3.17, 4.83 0.14 
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PC aa C28:1 1.07 0.84, 1.33 1.09 0.86, 1.66 0.41 PC ae C36:0 0.61 0.50, 0.71 0.54 0.45, 0.64 0.06 
PC aa C30:0 2.54 1.73, 3.57 2.37 1.80, 3.33 0.65 PC ae C36:1 4.06 3.16, 5.05 3.57 2.73, 4.47 0.03 
PC aa C30:2 0.43 0.33, 0.55 0.39 0.29, 0.52 0.17 PC ae C36:2 6.32 4.91, 8.25 5.82 4.81, 7.55 0.23 
PC aa C32:0 14.5 10.4, 17.6 12.2 10.2, 15.3 0.04 PC ae C36:3 3.64 2.84, 4.33 3.34 2.89, 3.95 0.16 
PC aa C32:1 10.6 6.0, 16.3 7.4 4.8, 12.1 0.003 PC ae C36:4 12.4 10.4, 15.4 11.5 9.79, 14.7 0.31 
PC aa C32:2 1.80 1.24, 2.29 1.76 1.29, 2.33 0.83 PC ae C36:5 10.1 7.7, 11.4 9.6 7.9, 12.6 0.64 
PC aa C32:3 0.24 0.20, 0.29 0.24 0.20, 0.28 0.45 PC ae C38:0 1.05 0.87, 1.33 1.01 0.84, 1.22 0.20 
PC aa C34:1 145.4 104.5, 173.6 118.1 93.4, 147.6 0.003 PC ae C38:1 0.42 0.29, 0.53 0.35 0.25, 0.45 0.008 
PC aa C34:2 214.4 182.2, 245.7 198.1 168.0, 227.0 0.03 PC ae C38:2 1.44 1.12, 1.97 1.26 1.00, 1.64 0.006 
PC aa C34:3 6.85 5.31, 8.77 5.63 3.99, 7.67 0.001 PC ae C38:3 2.14 1.77, 2.60 2.04 1.64, 2.52 0.33 
PC aa C34:4 0.81 0.65, 1.00 0.85 0.66, 1.12 0.29 PC ae C38:4 9.37 8.37, 11.09 9.33 8.02, 11.06 0.68 
PC aa C36:0 1.91 1.54, 2.57 1.80 1.33, 2.34 0.10 PC ae C38:5 13.6 10.8, 16.2 13.1 11.2, 15.5 0.57 
PC aa C36:1 32.0 25.5, 38.8 27.3 22.6, 34.3 0.001 PC ae C38:6 4.73 3.72, 5.85 4.55 3.86, 5.92 0.91 
PC aa C36:2 135.6 115.4, 150.7 127.4 107.4, 145.0 0.03 PC ae C40:1 0.76 0.62, 0.94 0.70 0.52, 0.85 0.03 
PC aa C36:3 68.8 55.8, 82.9 65.7 52.6, 74.8 0.14 PC ae C40:2 0.70 0.57, 0.85 0.66 0.54, 0.81 0.23 
PC aa C36:4 137.8 115.4, 150.7 132.4 111.9, 151.5 0.37 PC ae C40:3 0.65 0.54, 0.75 0.61 0.51, 0.73 0.22 
PC aa C36:5 6.95 5.12, 8.70 5.85 4.47, 8.04 0.01 PC ae C40:4 1.83 1.62, 2.12 1.76 1.53, 2.07 0.18 
PC aa C36:6 0.47 0.39, 0.58 0.49 0.38, 0.65 0.47 PC ae C40:5 2.57 2.21, 2.89 2.41 2.11, 2.85 0.07 
PC aa C38:0 2.43 2.15, 3.22 2.27 1.86, 2.92 0.08 PC ae C40:6 3.48 2.96, 4.01 3.40 2.86. 4.15 0.59 
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PC aa C38:1 0.79 0.54, 1.04 0.71 0.48, 0.97 0.29 PC ae C42:1 0.64 0.56, 0.74 0.57 0.45 0.71 0.007 
PC aa C38:3 34.1 29.7, 41.8 34.0 28.4, 40.7 0.45 PC ae C42:2 0.42 0.35, 0.50 0.38 0.29, 0.48 0.09 
PC aa C38:4 93.7 82.9, 108.8 98.6 79.0, 113.3 0.99 PC ae C42:3 0.48 0.40, 0.57 0.44 0.37, 0.55 0.11 
PC aa C38:5 33.7 28.2, 38.5 34.0 28.4, 40.7 0.45 PC ae C42:4 0.63 0.52, 0.72 0.60 0.51, 0.70 0.48 
PC aa C38:6 56.6 45.9, 68.4 56.1 43.8, 69.9 0.80 PC ae C42:5 1.54 1.37, 1.83 1.52 1.35, 1.73 0.15 
PC aa C40:2 0.31 0.28, 0.37 0.28 0.22, 0.36 0.05 PC ae C44:3 0.27 0.23, 0.31 0.25 0.21, 0.30 0.07 
PC aa C40:3 0.57 0.47, 0.64 0.52 0.41, 0.62 0.06 PC ae C44:4 0.32 0.27, 0.36 0.30 0.26, 0.34 0.06 
PC aa C40:4 4.51 3.67, 5.63 4.19 3.43, 5.26 0.17 PC ae C44:5 1.15 1.00, 1.30 1.09 0.91, 1.27 0.16 
PC aa C40:5 9.64 7.98, 11.66 9.57 7.88, 11.71 0.94 PC ae C44:6 1.66 1.50, 1.94 1.62 1.36, 1.88 0.06 
PC aa C40:6 24.9 19.2, 29.9 24.5 19.4, 30.1 0.67  
1Abbreviations for lipid nomenclature are described in the Methods section. 
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Supplementary Appendix 
 
SuperLearner1 is an ensembling approach to machine learning that involves two steps. First, multiple individual machine-learning 
classification algorithms (e.g., logistic regression) are implemented. Second, cross-validated results from the individual machine-
learning algorithms are combined via weighted average to minimize a cross-validated mean squared error (and potentially fit the data 
better than each individual algorithm). In the first step, only a portion of the data is used to train each algorithm. The second step 
combines estimates using the data that were left out of the training data, producing a cross-validated estimate. Cross-validated 
SuperLearner additionally leaves out a portion of data in the second step to produce cross-validated estimates of the weights. The idea 
behind SuperLearner is that no one machine-learning algorithm is optimal for all datasets. Performance of an algorithm depends on the 
underlying true functional form linking the features (e.g., metabolites) to the outcome (e.g., EED), which is unknown in practice. 
Thus, SuperLearner allows the researcher to try multiple machine-learning algorithms and optimally combines the results to find the 
lowest mean squared error. A schematic for SuperLearner can be found in the paper by Rose2. 
In the current study, we implemented SuperLearner so that it splits the data into 10 mutually exclusive and collectively 
exhaustive groups. We ensured that the proportions with and without EED were nearly identical in each group. We ran multiple 
machine-learning algorithms 10 times, each using 9/10ths of the data (the training data) with a different group omitted each time (test 
data). Estimated models of each machine-learning algorithm were then applied to the omitted group (1/10th of the data) to compute the 
cross-validated (CV) estimated probability of EED; i.e., leave 10% out cross validation. It is important to stress that the estimated 
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probabilities were derived from data that were not used to train the algorithms. The final Super Learner estimate involved computing 
the weighted average of the CV estimates of the individual machine-learning algorithms that minimized the Brier score (equivalent to 
mean-square error). The weighting was carried out using non-negative least squares regression of EED on cross-validated probabilities 
of EED estimated from each individual machine-learning algorithm.  
To further cross-validate the performance of the final Super Learner estimates (i.e., the coefficients, or weights, of the 
weighted average), we performed CV Super Learner, which splits the data into 10 mutually exclusive and collectively exhaustive 
groups, and performs Super Learner 10 times using 9/10ths of the data and leaves out a different 1/10th set each time. The final CV 
estimate was computed in the test data. We carried out Super Learner using the SuperLearner() and CV.SuperLearner() function in the 
SuperLearner package in R version 3.2.03. We selected 9 individual machine-learning algorithms: 1) glmnet() in the glmnet package 
with alpha=1 (least absolute shrinkage and selection operator [LASSO] regularization)4, 2) glmnet() with alpha=0 (ridge regression 
regularization)4, 3) glmnet() with alpha=0.5 (elastic net regularization, which is a hybrid of LASSO and ridge regression 
regularization)4, 4) gbm() in the gbm package (generalized boosted regression)4,5 with 10,000 trees and interaction depth = 2, 5) 
randomForest() in the randomForest package (random forest ensemble of classification and regression trees) with 1,000 trees6, 6) 
ipredbagg() in the ipred() package (bootstrap aggregation [BAGGing] of classification and regression trees)6 with 100 replicates, 7) 
polymars() in the polspline package (adaptive regression using piecewise linear splines)8,9, 8) earth() in the earth package10 (another 
implementation of adaptive regression using piecewise linear splines)11, and 9) bayesglm() in the arm package (main-effects Bayesian 
logistic regression) with a Cauchy prior with scale=2.5. 
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We computed multiple metrics to assess the cross-validated (i.e., in testing data not used to fit the models) performance of CV 
Super Learner, Super Learner, and the individual machine-learning algorithms (Supplementary Appendix Table 1). We computed the 
ROC curves (Supplementary Figure 3), and measures of discrimination including CV R2 and area under the ROC curve (AUC) with 
95% confidence intervals. We also assessed model calibration using Brier scores, means (i.e., probabilities) of true EED status within 
strata of estimated probabilities, and the Hosmer-Lemeshow goodness-of-fit chi-square test12 where p-value <0.05 is considered 
significant evidence of lack of fit. 
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Supplementary Appendix Table 1.  
Metrics for discrimination and calibration of classification modeling using the Super Learner algorithm 
 
Algorithm Coefficientsa Cross Validatedb Measures of 



















CV Super Learner  0.160 0.048 0.679 0.610, 0.747 0.613 0.675 0.691 0.898 0.818 0.964 0.701 
Super Learner  0.156 0.073 0.701 0.632, 0.771 0.593 0.537 0.810 0.788 0.870 0.944 0.224 
LASSO 0 0.159 0.051 0.681 0.611, 0.752 0.667 0.550 0.760 0.808 0.903 0.927 0.467 
Ridge 0.29 0.157 0.067 0.699 0.630, 0.768 0.714 0.500 0.765 0.843 0.887 0.936 0.168 
Elastic Net 0 0.159 0.055 0.684 0.613, 0.755 0.700 0.500 0.776 0.825 0.918 0.925 0.245 
GBM 0.202 0.158 0.057 0.684 0.614, 0.753 0.579 0.657 0.716 0.833 0.904 0.900 0.515 
Random Forest 0.126 0.161 0.039 0.677 0.605, 0.748 0.553 0.720 0.811 0.744 0.857 0.923 0.029 
MARS (polymars) 0 0.170 -0.015 0.550 0.471, 0.629 0.579 0.783 0.781 0.875 0.889 0.853 <0.001 
MARS (earth) 0.013 0.188 -0.121 0.646 0.570, 0.722 0.627 0.759 0.756 0.762 0.833 0.864 <0.001 
Bayes GLM 0.368 0.158 0.060 0.690 0.619, 0.761 0.532 0.769 0.763 0.767 0.867 0.909 0.270 
BAGGed CART 0 0.161 0.043 0.677 0.585, 0.730 0.605 0.649 0.735 0.829 0.884 0.894 0.312 
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Abbreviations: BAGGed CART, bootstrap aggregated classification and regression tree; CV, cross-validated; LASSO, least absolute 
shrinkage and selection operator; GBM, generalized boosted regression; GLM, generalized linear model (i.e., main effects logistic 
regression); MARS, multivariate adaptive regression splines 
aWeights of the individual algorithms for the Super Learner estimate 
bCross-validated; i.e., computed in data omitted from algorithm training set. 
cMeans (proportions) with EED, in strata defined by cross-validated probabilities estimated from the algorithms. In well-calibrated 
models, the means should fall within the ranges of the strata.  
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FIGURE LEGENDS 
 
Supplementary Figure 1. Heat map showing the relationship of serum amino acids, biogenic amines, amino acid metabolites, 
acylcarnitines, and sphingolipids by gut permeability (L:M ratio). L:M ratio is categorized in deciles. Abbreviations for lipid 
nomenclature and other metabolites are described in the methods section. 
 
Supplementary Figure 2. Heat map showing the relationship of serum glycerophospholipids by gut permeability (L:M ratio). L:M 
ratio is categorized in deciles. Abbreviations for lipid nomenclature and other metabolites are described in the methods section. 
 
Supplementary Figure 3. Cross-validated receiver operating curves of the relationship of the 14 significant serum metabolites with 
EED using Super Learner, cross-validated (CV) Super Learner, and nine other algorithms. Abbreviations: BAGGed CART, bootstrap 
aggregated classification and regression tree; CV, cross-validated; LASSO, least absolute shrinkage and selection operator; GBM, 
generalized boosted regression; GLM, generalized linear model (i.e., main effects logistic regression); MARS, multivariate adaptive 
regression splines  
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Supplementary Figure 3 
 
 
